Reliability and Validity of Mini-Balance Evaluation System Test (Mini-BESTest) in Type II Diabetic Patients with Peripheral Neuropathy

Not Applicable

Recruiting

• Conditions: Type 2 diabetic patients with peripheral neuropathy; Mini- T2DPN; BESTest

• Registration Number: TCTR20200305006
• Lead Sponsor: /A

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-03-05
• Study Completion: 2020-08-27
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 36

Inclusion Criteria

1) Patients aged between 40 †70 years and both sexes
2) Diagnosis as type 2 diabetes with well-controlled blood glucose based on follow up three times of medical assessments according to medical records
3) Screened with Michigan Neuropathy Screening Instrument (MNSI) and have a MNSI score ≥ 2.5 out of 10 by the researcher (Herman et al. 2012)
4) Diabetic duration of more than 5 years according to the medical record
5) Able to understand the instructions by mini-mental state examination (MMSE) (Roman de Mettelinge et al., 2013)

Exclusion Criteria

1) Diagnosis as peripheral venous insufficiency, cardiac, renal or hepatic insufficiency, uncontrolled hypertension or myopathic by medical record
2) Diagnosis as central nervous system dysfunction (such as stroke, Parkinson’s disease, and cerebral ataxia) by medical record
3) Foot ulcers by physical examination
4) Fracture of the lower limbs within the 6 months before the study by physical examination
5) Partial or complete blindness by physical examination
6) Severe auditory problems by physical examination (Chatchawan, Eungpinichpong, Plandee, & Yamauchi, 2015) (Marques et al. 2017)

Study & Design

• Study Type: Observational
• Study Design: Not specified